Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL) includes at
least one-quarter of all adults with ALL. Until recently, conventional chemotherapy programs …

Background Children with Philadelphia chromosome–positive acute lymphoblastic leukemia
(Ph-positive ALL) have a poor prognosis, and there is no consensus on the optimal …

Acute lymphoblastic leukemia (ALL) is a heterogeneous disorder, with the greatest
prevalence in children, but it also affects adults, and has an increasing incidence with age …

Importance The incidence of acute lymphoblastic leukemia (ALL) and lymphoblastic
lymphoma (LBL) in adolescent and young adult (AYA) patients (age range, 15-39 years) in …

Acute lymphoblastic leukaemia (ALL) is the commonest childhood cancer and an important
cause of morbidity from haematological malignancies in adults. In the past several years, we …

New therapies for Philadelphia chromosome–like acute lymphoblastic leukemia (Ph-like
ALL) patients are urgently needed. The genetic landscape of Ph-like ALL is characterized by …

Among 3,638 children with acute lymphoblastic leukemia (ALL) entered on Pediatric
Oncology Group (POG) protocols between June 1981 and April 1989, successful …

Abstract The Philadelphia chromosome (Ph), t (9; 22), is seen in about 20% to 30% of adults
diagnosed with acute lymphoblastic leukemia (ALL). It has been associated with poorer …

BACKGROUND The long‐term efficacy of a combination of chemotherapy and dasatinib in
patients with Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL) …

From 1994 to 2000, 154 adults with Philadelphia chromosome–positive (Ph+) and/or BCR-
ABL+ acute lymphoblastic leukemia (ALL) were treated according to a prospective trial …